Hello User
Sign in
Hello
Sign Out
Subscribe
Next Story
Business News/ News / India/  3 PEs offload 8% in Mankind

3 PEs offload 8% in Mankind

  • The PE firms cumulatively sold 16.08 million shares for 2,948 crore at 1832.46 per share on the NSE

Founded by Ramesh Juneja, Mankind Phrama became a fully integrated pharmaceutical company in 1995. (Photo: Reuters)

Mumbai: Mankind Pharma Ltd’s shares declined 3.5% to 1853.10 on Tuesday following the execution of a bulk deal by private equity firm Beige Ltd.

Beige offloaded 3.59% of its holding, or 14.4 million shares, for 2,640.55 crore on the BSE at 1,832.43 per share. On 30 September it held 7.46% in the company. In a separate transaction on the NSE, Beige, along with two other PE funds, H.ema Cipef (I) and Cairnhill Cipef, offloaded about 4% stake in the pharma major collectively.

According to data from NSE Hema Cipef (I) Ltd sold a 1.4% stake, or 5.6 million shares, for 1,031.16 crore, Cairnhill Cipef divested 1.7%, or 6.96 million shares, for 1275.68 crore, and Beige offloaded a 0.87% stake, or 3.5 million shares for 641.3 crore. The PE firms cumulatively sold 16.08 million shares for 2,948 crore at 1832.46 per share. Post-transaction, Biege’s holdings in Mankind is at 3.86%. Meanwhile, Kotak Funds-India Midcap Fund capitalized on the dip, acquiring a 0.5% stake in the company by purchasing 2.03 million shares for 371.8 crore.

Founded by Ramesh Juneja, Mankind Phrama became a fully integrated pharmaceutical company in 1995. It specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, and manufactures some of the most widely-used consumer healthcare products, including Manforce Condoms, Prega News pregnancy test kits, and the Unwanted-72 emergency contraceptive.

In India’s consumer healthcare sector, Manforce has a 30% market share, leading the male condom category . Prega leads pregnancy test kit markets, commanding 80% share, and Unwanted-72 leads the emergency contraceptive category, with a 62% market share.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

ABOUT THE AUTHOR

Mayur Bhalerao

"Mayur spearheads data-driven reporting on IPOs for Mint. He also covers market trends, and corporate announcements to ensure comprehensive coverage of the financial landscape. Mayur believes in harnessing the power of Bloomberg Terminal and Capital Line to extract and disseminate critical financial data to cross-functional teams within the newsroom and beyond. disseminate critical financial data to cross-functional teams within the newsroom and beyond."
Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
Get the latest financial, economic and market news, instantly.